[
  {
    "ts": null,
    "headline": "MRNA Therapeutics and Global Markets Report 2025: Revenue Data from 2022-2024, Estimates for 2025, and CAGR Projections Through 2030",
    "summary": "The mRNA therapeutics market offers key opportunities in developing vaccines and treatments for chronic and infectious diseases, driven by successful clinical trials and increased government and industry focus. mRNA shows promise in safety, distribution, and therapeutic efficiency, opening pathways for innovations beyond COVID-19 vaccines.Dublin, Oct. 16, 2025 (GLOBE NEWSWIRE) -- The \"mRNA: Therapeutics and Global Markets\" report has been added to ResearchAndMarkets.com's offering.The global mar",
    "url": "https://finnhub.io/api/news?id=ff0d4ea05a3ef215c79d648d62ac0891850999ec23f638c8063bd99d53fc6801",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760619780,
      "headline": "MRNA Therapeutics and Global Markets Report 2025: Revenue Data from 2022-2024, Estimates for 2025, and CAGR Projections Through 2030",
      "id": 137104961,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "The mRNA therapeutics market offers key opportunities in developing vaccines and treatments for chronic and infectious diseases, driven by successful clinical trials and increased government and industry focus. mRNA shows promise in safety, distribution, and therapeutic efficiency, opening pathways for innovations beyond COVID-19 vaccines.Dublin, Oct. 16, 2025 (GLOBE NEWSWIRE) -- The \"mRNA: Therapeutics and Global Markets\" report has been added to ResearchAndMarkets.com's offering.The global mar",
      "url": "https://finnhub.io/api/news?id=ff0d4ea05a3ef215c79d648d62ac0891850999ec23f638c8063bd99d53fc6801"
    }
  },
  {
    "ts": null,
    "headline": "Moderna to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025",
    "summary": "CAMBRIDGE, MA / ACCESS Newswire / October 16, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, November 6, 2025 to report its third quarter 2025 financial results, ...",
    "url": "https://finnhub.io/api/news?id=b45ec8b92644f8a0dc773f1f0711b724d40a2b1c4560854f2c3a39f21871e51a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760612400,
      "headline": "Moderna to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025",
      "id": 137104962,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "CAMBRIDGE, MA / ACCESS Newswire / October 16, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, November 6, 2025 to report its third quarter 2025 financial results, ...",
      "url": "https://finnhub.io/api/news?id=b45ec8b92644f8a0dc773f1f0711b724d40a2b1c4560854f2c3a39f21871e51a"
    }
  }
]